Pancytopenia in a Dog Induced by Concomitant Use of Myelotoxic Drugs

Gabriela Oliveira da Paz Augusto Pinto, Thais Ribeiro Pena Paiva, Giovana Scuissiatto de Souza, Weslley Junior de Oliveira, Rosangela Locatelli-Dittrich

Abstract


Background: The indiscriminate use of drugs is an issue in Veterinary Medicine, as it has serious consequences for the animals. Many drugs are myelotoxic and cause a decrease in the production of blood cells, which may be irreversible in some cases. The present work reports a case of pancytopenia induced by the concomitant use of myelotoxic drugs (estrogen, metamizole and phenobarbital) in a dog and describes findings on myelotoxicity, hematological alterations and treatment success.


Case: A 7-year-old Lhasa Apso bitch was referred to the Veterinary Hospital of Federal University of Paraná, Curitiba campus, with hematuria and a history of treatment with phenobarbital [2 mg/kg twice a day (bis in die, BID)], metamizole [25 mg/kg three times a day (ter in die, TID)], and use of estrogen hormone (estradiol cypionate). At physical examination, the animal was normohydrated and exhibited normal palpable lymph nodes, pale mucous membranes, galactorrhea, and a body temperature of 36°C. A complete blood count including reticulocyte count and a total plasma protein (TPP) exam were requested. The results revealed pancytopenia (18% hematocrit, 1,400 total leucocytes/µL, and 22,000 reticulocytes/µL). An abdominal ultrasound exam did not detect any relevant alterations. In view of the results obtained, medullary aplasia was suspected. A bone marrow aspiration was performed. A myelogram revealed a decrease in cellularity (erythrocytic and granulocytic hypoplasia), with presence of rare erythroid and granulocytic precursors. The diagnosis was medullary aplasia. The animal was treated, and the evolution of the hematological alterations was monitored. The treatment consisted of administration of erythropoietin (100UI/kg subcutaneously every 48 h), prednisone (2 mg/kg BID), Leucogen (3 mg/kg BID), interferon (0.2 IU/kg BID) and Eritrós Dog Tabs [1 tablet once a day (semel in die, SID)]. After five days of treatment, the patient’s clinical picture improved (30% hematocrit, 5,300 total leukocytes/µL, 84,000 platelets/µL, and 195,000 reticulocytes/µL), and the hematological alterations were resolved after 25 days of treatment (43% hematocrit, 5,100 total leukocytes/µL, and 333,000 platelets/µL). The bitch was discharged after 89 days of treatment.


Discussion: The hematological alterations found in the patient were consistent with pancytopenia, and the myelogram allowed the establishment of a diagnosis of medullary aplasia. There are various causes of pancytopenia in dogs; in this case, it was caused by medications, as the drugs administered to the patient (estrogens, metamizole, and phenobarbital) are myelotoxic. Canine bone marrow is susceptible to suppression by estrogens, which can induce medullary aplasia even with a single dose. No reports on hematological alterations caused by dipyrone (metamizole) in dogs were found; however, in humans, development of aplastic anemia, agranulocytosis, nephrotoxicity, and allergic reactions have been attributed to the use of this drug. Phenobarbital can cause adverse reactions that lead to anemia, leukopenia, and thrombocytopenia. Evaluating the bone marrow of animals with pancytopenia is important because this procedure allows the establishment of a diagnosis that may prompt treatment while hematopoietic precursors are still present in the bone marrow. In this case, a treatment using hematopoietic stimulants was employed owing to the presence of erythrocytic and myelocytic precursors in the patient’s bone marrow. The treatment instituted was efficacious, as only five days of therapy already improved the hematological condition of the patient, who was discharged after 89 days of treatment.


Full Text:

PDF

References


Bersan E., Volk H.A., Ros C. & Risio L. 2014. Phenobarbitone-induced haematological abnormalities in the idiopatic epileptic dogs: prevalence, risk factors, clinical presentation and outcome. Veterinary Record. 175(10): 247.

Brazzell J.L. & Weiss D.J. 2006. A retrospective study of aplastic pancytopenia in the dog: 9 cases (1996-2003). Veterinary Clinical Pathology. 35(4): 413-417.

Brockus C.W. 1998. Endogenous estrogen myelotoxicosis associated with functional cystic ovaries in a dog. Veterinary Clinical Pathology. 27(2): 55-56.

Conrado F.O., Rodrigues B.Á., Lacerda L.A., Lasta C.S., Esteves V.S. & González F.H.D. 2009. Use of lithium carbonate in the treatment of a suspected case of oestrogen-induced bone marrow aplasia in a bitch. Veterinary Record. 164(9): 274-275.

Echeverri D. & Rodríguez V. 2007. Pancitopenia en un canino ocasionada por la administración de estrógenos para evitar uma preñez no deseada. Revista MVZ Córdoba. 12(2): 1068-1076.

Fielder S.E. 2019. Hematologic reference ranges. MSD Manual - Veterinary Manual. [Fonte:].

Girard A.F., Campos A.N., Pescador C.A., Almeida A.B.P.F.A., Mendonça A.J., Nakazato L., Oliveira A.C.S. & Sousa V.R.F. 2007. Quantitative analysis of bone marrow in pancitopenic dogs. Semina: Ciências Agrárias. 38(6): 3639-3646.

Harvey J.W. 2012. Evaluation of Erythrocytes. In: Veterinary Hematology - A Diagnostic Guide and Color Atlas. Gainesville: Elsevier, pp.109-110.

Ibáñez L., Vidal X., Ballarín E. & Laporte J.R. 2005. Agranulocytosis associated with dipyrone (metamizol). European Journal of Clinical Pharmacology. 60(11): 821-829.

Isik M., Kaya Z., Bellen F., Aktas A., Tezer H. & Gürsel T. 2014. Life-threatening agranulocytosis, anemia and plasmacytosis after Dipyrone use for fever in a child. Journal of Pediatric Hematology/Oncology. 36(1): 46-48.

Jacobs G., Calvert C. & Kaufman A. 1998. Neutropenia and thrombocytopenia in three dogs treated with anticonvulsivants. Journal of the American Veterinary Medical Association. 212(5): 681-684.

Jung H.B., Kang M.H. & Park H.M. 2015. Drug-induced blood cell dyscrasia associated with phenobarbital administration in a dog. Korean Journal of Veterinary Research. 55(4): 263-266.

Kearns S. & Ewing P. 2006. Causes of canine and feline pancytopenia. Internal medicine compendium. 28(2): 122-133.

Khoutorsky A. & Bruchim Y. 2008. Transient leucopenia, thrombocytopenia and anaemia associated with severe acute phenobarbital intoxication in a dog. Journal of Small Animal Practice. 49(7): 367-369.

Lucchetti G., Granero A.L., Almeida L.G.C. & Battistella V.M. 2010. Pancitopenia associada ao uso de dipirona. Revista da Sociedade Brasileira de Clínica Médica. 8: 72-76.

Marsh J.C., Ball S.E., Darbyshire P., Gordon-Smith E., Keidan A., Martin A., McCann S., Mercieca J., Oscier D., Roques A. & Yin J. 2003. Guidelines for the diagnosis and management of acquired aplastic anemia. British Journal of Haematology 123(5): 782-801.

Mischke R. & Busse L. 2002. Reference values for the bone marrow aspirates in adult dogs. Journal of Veterinary Medicine Series A. 49(10): 499-502.

Moraes L.F. & Takahira R.K. 2010. Aplasia medular em cães. Revista de Ciências Agroveterinárias. 9(1): 99-108.

Sanpera N., Masot N., Janer M., Romeo C. & de Pedro R. 2002. Oestrogen-induced bone marrow aplasia in a dog with a Sertoli cell tumour. Journal of Small Animal Practice. 43(8): 365-369.

Sontas H.B., Dokuzeylu B., Turna O. & Ekici H. 2009. Estrogen-induced myelotoxicity in dog: A review. The Canadian Veterinary Journal. 50(10): 1054-1058.

Von Klopmann T., Papenhagen H. & Tipold A. 2006. Phenobarbital-induced blood dyscrasia in a Shih-tzu. Tieraerztliche Praxis Ausgabe Kleintiere Heintier. 34(1): 40-44.

Weiss D.J. 1999. A retrospective study of canine pancytopenia. Veterinary Clinical Pathology. 28(3): 83-88.

Weiss D.J. 2003. News insights into the physiology and treatment of acquired myelodysplastic syndromes and aplastic pancytopenia. Veterinary Clinics of North America: Small Animal Practice. 33(6): 1317-1323.

Weiss D.J. 2005. Bone marrow necrosis in dogs: 34 cases (1996-2004). Journal of the American Veterinary Medical Association. 227(2): 263-267.

Weiss D.J. 2010. Drug-induced blood cell disorders. In: Weiss D.J. & Wardrop K.J. (Eds). Schalm’s Veterinary Hematology. 6th edn. Pullman: Wiley-Blackwell, pp.99-105.

Weiss D.J. 2010. Aplastic anemia. In: Weiss D.J. & Wardrop K.J. (Eds). Schalm’s Veterinary Hematology. 6th edn. Pullman: Wiley-Blackwell, pp.256-260.

Weiss D.J. & Smith S.A. 2002. A retrospective study of cases of canine myelofibrosis. Journal of Veterinary Internal Medicine. 16(2): 174-178.

Wellman M.L. & Radin M.J. 2004. Cytologic and Histologic Evaluation of the Bone Marrow. In: Bone Marrow Evaluation in Dogs and Cats. St. Louis: Nestlé Purina PetCare Co., 18p.

Yetgin S., Özyürek E., Aslan D. & Çetin M. 2004. Metamizole sodium-induced severe aplastic anemia and its recovery with a short-course steroid therapy. Pediatric Hematology and Oncology. 21(4): 343-347.

Zaccara G., Franciotta D. & Perucca E. 2007. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 48(7): 1223-1244.




DOI: https://doi.org/10.22456/1679-9216.111295

Copyright (c) 2021 Gabriela Oliveira da Paz Augusto Pinto

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.